Table 2 GBM cell line phenotypes.
Patient | Reference number | Doubling time (hours) | IDH1 status | MGMT methylation | Xenograft median survival (days) |
|---|---|---|---|---|---|
BAH1 | QIMR-B001 | 79.5 +/− 3.3 | WT | Methylated | 210 +/− 8 |
FPW1 | QIMR-B002 | 48.1 +/− 4.7 | WT | Unmethylated | 196 +/− 4 |
HW1 | QIMR-B003 | 55.8 +/− 2.7 | WT | Methylated | 174 +/− 14 |
JK2 | QIMR-B004 | 94.2 +/− 6.0 | WT | Unmethylated | 147 +/− 9 |
MMK1 | QIMR-B005 | 52.4 +/− 4.5 | WT | Unmethylated | 157 +/− 15 |
MN1 | QIMR-B006 | 44.9 +/− 1.0 | WT | Unmethylated | 258 +/− 20 |
PB1 | QIMR-B007 | 79.4 +/− 6.3 | WT | Unmethylated | 71 +/− 1 |
RKI1 | QIMR-B008 | 72.9 +/− 5.3 | WT | Methylated* | 248 +/− 6 |
RN1 | QIMR-B009 | 37.5 +/− 1.9 | WT | Unmethylated | 81 +/− 2 |
SB2b | QIMR-B010 | 108.7 +/− 6.9 | WT | Methylated | 120 +/− 4 |
SJH1 | QIMR-B011 | 67.3 +/− 4.7 | WT | Unmethylated | 148 +/− 2 |
WK1 | QIMR-B012 | 46.2 +/− 1.0 | WT | Unmethylated | 150 +/− 2 |
